Since a re-evaluation of the HER2 status of surgically removed breast cancer tissue was not available for all patients included in this study, it was not possible to calculate the sensitivity and specificity for the combined analysis of the frequency and HER2 expression level of EVs to correctly detect the HER2 expression of breast cancer tissue. The gene discussed is ERBB2; the disease is breast carcinoma.